一个简单的四个基于症状的BEDS得分来预测慢性便秘患者的异能排便
Mayank Jain1, Vinodini Agrawal2
1Department of Gastroenterology, Arihant Hospital and Research Centre, 283-A Gumasta Nagar, Indore, 452 009, India. mayank4670@rediffmail.com.
概括
BEDS症状评分可以帮助识别患有异常排便 (DD) 的患者,这是异常功能障碍. 2或更高的得分表明,患有慢性便秘的人患DD的可能性更高.
科学领域:
- 胃肠病学 胃肠病学
- 结肠直肠手术 结肠直肠手术
- 盆地底疾病 盆地底疾病
背景情况:
- 失同性排便 (DD) 是一种功能性直肠疾病,涉及排便期间的骨盆底功能障碍.
- 之前的印度研究为BEDS症状评分的发展提供了信息.
- 该BEDS评分评估了诸如出血,紧张,数字化和不完全疏散等症状.
研究的目的:
- 确定设计的BEDS症状评分是否可以识别患有慢性便秘的患者,他们可能患有DD.
- 为了评估DD的BEDS得分的诊断准确性.
主要方法:
- 一项前性观察队列研究包括244名患有慢性便秘的成年患者,接受了直肠计量 (ARM).
- 患者在ARM之前完成了BEDS症状得分.
- 统计分析包括灵敏度,特异性,PPV,NPV和科恩的卡帕系数.
主要成果:
- 在244名患者中,104名 (42.6%) 被诊断为DD.
- 不完全疏散,过度紧张和数字化等症状在DDD患者中更为普遍.
- 一个BEDS得分≥2显示了69.2%的敏感性和81.4%的特异性DD.
结论:
- 具有≥2的切割值的BEDS症状得分是识别异能排便患者的有用工具.
- 该得分有助于区分慢性便秘患者之间的DD.
更多相关视频
相关概念视频
01:25Assessment of the Rectum and Anus
161
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
161
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
145
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
145
01:21Drugs for Treatment of Constipation-Predominant IBS
139
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
139
01:17Assessment of the Gastrointestinal System I: Subjective Data
152
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
152
01:17Drugs for Treatment of Diarrhea-Predominant IBS
149
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
149
01:29Assessment of the Gastrointestinal System II: Health Perception Pattern
80
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
80